Your browser doesn't support javascript.
loading
MicroRNA­126 protects SH­SY5Y cells from ischemia/reperfusion injury­induced apoptosis by inhibiting RAB3IP.
Sun, Zhumei; Zhao, Xu; Zhang, Meihang; Li, Ning; Zhao, Yanning; Chen, Changxiang; Li, Jianmin; Guo, Yanjuan; Feng, Qiang.
Afiliação
  • Sun Z; Department of Clinical Medicine, North China University of Science and Technology, Tangshan, Hubei 063210, P.R. China.
  • Zhao X; Department of Neurosurgery, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hubei 063000, P.R. China.
  • Zhang M; Department of Clinical Medicine, North China University of Science and Technology, Tangshan, Hubei 063210, P.R. China.
  • Li N; Department of Neurosurgery, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hubei 063000, P.R. China.
  • Zhao Y; Department of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hubei 063210, P.R. China.
  • Chen C; Department of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hubei 063210, P.R. China.
  • Li J; Department of Clinical Medicine, North China University of Science and Technology, Tangshan, Hubei 063210, P.R. China.
  • Guo Y; Department of Neurosurgery, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hubei 063000, P.R. China.
  • Feng Q; Department of Cardiology, Handan Central Hospital, Handan, Hubei 056001, P.R. China.
Mol Med Rep ; 25(2)2022 02.
Article em En | MEDLINE | ID: mdl-34935056
ABSTRACT
MicroRNA (miR)­126 is known to inhibit inflammatory responses in various inflammatory­related diseases, but its role during the cerebral ischemia/reperfusion (I/R) injury remains unknown. The present study aimed to examine the interaction between miR­126 and RAB3A interacting protein (RAB3IP), and explore its potential protective effects during I/R injury. The human neuroblastoma cell line SH­SY5Y was cultured in an oxygen­glucose deprivation/reoxygenation (OGD/R) environment to simulate I/R injury to assess miR­126 expression and cell viability. SH­SY5Y cells cultured in normal conditions were used as a negative control (NC) group. SH­SY5Y cells were transfected with a miR­126 mimic or an NC mimic, then cultured in OGD/R conditions; in rescue experiments, SH­SY5Y cells were co­transfected with RAB3IP overexpression or NC plasmid together with mimic­NC or mimic­miR, and then maintained in an OGD/R environment to evaluate miR­126, RAB3IP expression, cell viability and apoptosis. Cell viability was reduced in the Model group compared with the NC group, suggesting the successful construction of the OGD/R model. miR­126 expression was downregulated in the Model group compared with the NC group. However, following transfection with mimic­miR, cell viability increased compared with the mimic­NC group. Annexin V and PI staining and Hoechst/PI assays also indicated that apoptosis was reduced in the mimic­miR group compared with the mimic­NC group. RAB3IP expression was reduced following mimic­miR transfection. In rescue experiments, miR­126 negatively regulated RAB3IP expression; by contrast, RAB3IP did not affect that of miR­126. In addition, RAB3IP overexpression attenuated the protective effect of miR­126 on OGD/R­induced apoptosis. These findings suggest that miR­126 protects against cerebral I/R injury by targeting RAB3IP.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Ciclo Celular / Apoptose / Fatores de Troca do Nucleotídeo Guanina / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Ciclo Celular / Apoptose / Fatores de Troca do Nucleotídeo Guanina / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2022 Tipo de documento: Article